Nathaniel S. Gardiner Insider Trading $ENTA ENANTA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nathaniel S. Gardiner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nathaniel S. Gardiner. Nathaniel S. Gardiner is Sr. VP & General Counsel in ENANTA PHARMACEUTICALS INC ($ENTA).
Nathaniel S. Gardiner in ENANTA PHARMACEUTICALS INC
Trading Symbol: ENTAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nathaniel S. Gardiner: Sr. VP & General Counsel
Holdings: 43,788 shares
Current Value: $1,409,974
Latest Transaction: Dec 16 2020
$ENTA Market Capitalization: $593.41M
$ENTA Previous Close: $32.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nathaniel S. Gardiner in ENANTA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 0.00 | 5,250 | 0 | 0 | |
Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 42.52 | 1,540 | 65,481 | 42,248 | 43.8 K to 42.2 K (-3.52 %) |
Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 0.00 | 5,250 | 0 | 43,788 | 38.5 K to 43.8 K (+13.62 %) |
Dec 07 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 1,667 | 50,010 | 13,667 | |
Dec 07 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 1,667 | 50,010 | 38,538 | 36.9 K to 38.5 K (+4.52 %) |
Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 43.57 | 30,800 | 1,341,956 | 30,800 | |
Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 7,600 | 0 | 36,871 | 29.3 K to 36.9 K (+25.96 %) |
Aug 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 1,666 | 49,980 | 15,334 | |
Aug 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 1,666 | 49,980 | 29,271 | 27.6 K to 29.3 K (+6.04 %) |
Mar 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 3,000 | 90,000 | 17,000 | |
Mar 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 3,000 | 90,000 | 27,605 | 24.6 K to 27.6 K (+12.19 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 52.76 | 940 | 49,594 | 24,605 | 25.5 K to 24.6 K (-3.68 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,475 | 0 | 25,545 | 23.1 K to 25.5 K (+10.73 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 412 | 0 | 23,070 | 22.7 K to 23.1 K (+1.82 %) |
Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 0.00 | 5,250 | 0 | 5,250 | |
Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 63.88 | 2,331 | 148,904 | 22,658 | 25 K to 22.7 K (-9.33 %) |
Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 0.00 | 5,250 | 0 | 24,989 | 19.7 K to 25 K (+26.60 %) |
Nov 25 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 31.42 | 1,592 | 50,021 | 19,818 | |
Nov 25 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 31.42 | 1,592 | 50,021 | 19,739 | 18.1 K to 19.7 K (+8.77 %) |
Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 63.35 | 30,000 | 1,900,500 | 30,000 | |
Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 5,000 | 150,000 | 20,000 | |
Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 5,000 | 150,000 | 19,871 | 14.9 K to 19.9 K (+33.62 %) |
Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 5,000 | 150,000 | 20,000 | |
Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 5,000 | 150,000 | 19,871 | 14.9 K to 19.9 K (+33.62 %) |
Jun 26 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 31.42 | 3,295 | 103,529 | 21,410 | |
Jun 26 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 31.42 | 3,295 | 103,529 | 14,871 | 11.6 K to 14.9 K (+28.46 %) |
Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 31.42 | 795 | 24,979 | 24,705 | |
Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 1,724 | 59,823 | 70,976 | |
Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 31.42 | 795 | 24,979 | 26,497 | 25.7 K to 26.5 K (+3.09 %) |
Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 1,724 | 59,823 | 25,702 | 24 K to 25.7 K (+7.19 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Sell | S | 95.28 | 3,270 | 311,562 | 23,978 | 27.2 K to 24 K (-12.00 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Sell | S | 95.28 | 3,270 | 311,562 | 23,978 | 27.2 K to 24 K (-12.00 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 88.88 | 4,579 | 406,982 | 27,248 | 31.8 K to 27.2 K (-14.39 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 88.88 | 4,579 | 406,982 | 27,248 | 31.8 K to 27.2 K (-14.39 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 10,000 | 0 | 31,827 | 21.8 K to 31.8 K (+45.81 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 10,000 | 0 | 31,827 | 21.8 K to 31.8 K (+45.81 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 4,000 | 0 | 21,827 | 17.8 K to 21.8 K (+22.44 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 4,000 | 0 | 21,827 | 17.8 K to 21.8 K (+22.44 %) |
Jan 24 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 2,000 | 69,400 | 72,700 | |
Jan 24 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 2,000 | 69,400 | 17,827 | 15.8 K to 17.8 K (+12.64 %) |
Dec 06 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 2,000 | 69,400 | 74,700 | |
Dec 06 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 2,000 | 69,400 | 15,827 | 13.8 K to 15.8 K (+14.46 %) |
Nov 20 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 81.20 | 18,000 | 1,461,600 | 18,000 | |
Oct 02 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 1,500 | 52,050 | 76,700 | |
Oct 02 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 1,500 | 52,050 | 13,827 | 12.3 K to 13.8 K (+12.17 %) |
Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 76.85 | 2,065 | 158,685 | 12,327 | 14.4 K to 12.3 K (-14.35 %) |
Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 4,822 | 0 | 14,392 | 9.6 K to 14.4 K (+50.39 %) |
Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,000 | 0 | 9,570 | 7.6 K to 9.6 K (+26.42 %) |
Feb 12 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 4,300 | 149,210 | 78,200 | |
Feb 12 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 4,300 | 149,210 | 7,570 | 3.3 K to 7.6 K (+131.50 %) |
Nov 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 48.52 | 21,500 | 1,043,180 | 21,500 | |
Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 29.82 | 830 | 24,746 | 3,270 | 4.1 K to 3.3 K (-20.24 %) |
Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,200 | 0 | 4,100 | 1.9 K to 4.1 K (+115.79 %) |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 30.00 | 25,000 | 750,000 | 25,000 | |
May 12 2016 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 24.45 | 500 | 12,223 | 1,900 | 1.4 K to 1.9 K (+35.71 %) |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 31.42 | 25,500 | 801,210 | 25,500 | |
Feb 17 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 33.10 | 400 | 13,240 | 1,400 | 1,000 to 1.4 K (+40.00 %) |
Feb 17 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 33.47 | 600 | 20,082 | 1,000 | 400 to 1,000 (+150.00 %) |
Feb 17 2015 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | P | 33.00 | 400 | 13,200 | 400 | 0 to 400 |
Nov 21 2014 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 44.00 | 27,500 | 1,210,000 | 27,500 | |
May 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 34.70 | 82,500 | 2,862,750 | 82,500 |
Page: 1